Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
Endocrine diseases as causes of secondary hyperlipidemia
Łukasz Bułdak1, Bogdan Marek2, Dariusz Kajdaniuk2
1Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland. lbuldak@gmail.com.
Insights
This review analyzes how endocrine diseases and diabetes impact lipid profiles, affecting cardiovascular disease risk. It highlights the importance of identifying these secondary causes for effective hyperlipidemia management.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Cardiovascular diseases (CVDs) are a major global health burden.
- Hyperlipidemia, particularly hypercholesterolemia, is a key risk factor for atherosclerosis and CVD.
- Secondary causes of lipid abnormalities, including endocrine diseases and diabetes, require careful exclusion.
Purpose of the Study:
- To comprehensively review the impact of endocrine diseases and diabetes on lipid profiles.
- To analyze the incidence, clinical features, and therapeutic strategies for hyperlipidemias in patients with endocrine conditions.
Main Methods:
- Systematic literature review of publications on hyperlipidemia in endocrine disease and diabetes.
- Analysis of data on lipid profiles, clinical manifestations, and treatment outcomes.
Main Results:
- Endocrine diseases and diabetes significantly influence lipid profiles, contributing to cardiovascular risk.
- Specific endocrine disorders present distinct patterns of dyslipidemia.
- Management requires addressing both the underlying endocrine condition and lipid abnormalities.
Conclusions:
- Understanding the interplay between endocrine disorders, diabetes, and hyperlipidemia is crucial for CVD prevention.
- Integrated management approaches are necessary for optimizing patient outcomes.
- Further research is needed to elucidate specific mechanisms and refine therapeutic guidelines.
Abstract:
Cardiovascular diseases are among the leading causes of increased morbidity and mortality in developed and developing countries. One of the most important risk factors responsible for atherosclerosis and subsequent cardiovascular diseases is hyperlipidaemia. Currently, hyperlipidaemias are divided into several clinical entities. The greatest risk is associated with hypercholesterolaemia. As a result, modern guidelines for the treatment and prevention of atherosclerosis focus predominantly on the reduction of LDL-cholesterol. Hypertriglyceridaemia and atherogenic dyslipidaemia, which are responsible for a less significant increase in the cardiovascular risk, are nowadays secondary targets of the treatment. During the work-up for hyperlipidaemia one of the essential actions is the exclusion of secondary causes of the lipid abnormalities. Those include, among others, endocrine diseases, diabetes, drugs, nephrotic syndrome, and pregnancy. Data regarding the impact of endocrine disease and diabetes on the lipid profile are scattered. In this review, the authors aimed to perform a thorough analysis of the available publications regarding the topic and the preparation of a comprehensive review dealing with the incidence, clinical features, and the therapy of hyperlipidaemias in patients with endocrine disease.
More Related Videos
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Nephrotic Syndrome I : Introduction

